Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2015-12-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary personalized palliative care outcomes are expected to include:
* Reduced deviations from care plan as captured in the medical record compared to the group who did not receive early, integrated palliative care services
* Reduced hospital utilization compared to the group who did not receive early, integrated palliative care services
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Palliative Care + Standard of Care
Consenting patients will be approached by a research nurse to complete quality of life questionnaires (baseline measures) either in the oncology clinics or infusion clinics. Patients assigned to early palliative care will meet with a member of the palliative care team after enrollment and completion of the initial questionnaires to receive and review patient-oriented materials detailing palliative care services. Patients will then receive a comprehensive initial consult with a palliative care provider (a trained physician, nurse or nurse practitioner). Additional consults with the palliative care service will be scheduled approximately every 6 weeks for the duration of the study period (one year) at the discretion of the patient and palliative care provider.
Palliative Care
Components of the palliative care service intervention are expected to include:
* Establishment of a palliative care plan
* Care coordination by palliative care team
* Informational, patient friendly materials supporting Palliative Care
* Communication by palliative care team to all providers and teams involved in patient's care
* Systematic collection of information, including identification of surrogate or health care proxy and advance care planning
* Questionnaires capturing health related quality of life at regular intervals throughout the intervention period
Standard of Care
Patients will receive standard care from their oncologist. An assessment of health related quality of life will be conducted at regular oncology clinic visits at baseline and 3,6,9,and 12 months.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Palliative Care
Components of the palliative care service intervention are expected to include:
* Establishment of a palliative care plan
* Care coordination by palliative care team
* Informational, patient friendly materials supporting Palliative Care
* Communication by palliative care team to all providers and teams involved in patient's care
* Systematic collection of information, including identification of surrogate or health care proxy and advance care planning
* Questionnaires capturing health related quality of life at regular intervals throughout the intervention period
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Upcoming scheduled oncology clinic visit (2nd visit to the clinic) at Vanderbilt
* Ability to read and respond to questions in English
* Permission of oncology physician
Exclusion Criteria
* Participation in another clinical trial
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gordon Bernard
Professor of Medicine; Associate Vice-Chancellor for Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gordon Bernard, MD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
141854
Identifier Type: -
Identifier Source: org_study_id